BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 710491)

  • 1. Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
    Wyss M; Diez C; Balavoine JF; Martin D; Bouvier CA
    Eur J Cardiol; 1978 Oct; 8(3):337-47. PubMed ID: 710491
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
    Harker LA; Slichter SJ
    N Engl J Med; 1970 Dec; 283(24):1302-5. PubMed ID: 5478451
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
    Starkman C; Estampes B; Vernant P; Acar J
    Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719
    [No Abstract]   [Full Text] [Related]  

  • 6. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombogenic therapy by use of antiplatelet agents with warfarin--its efficiency for the outpatients with prosthetic valve].
    Saitoh H
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Nov; 36(11):2396-407. PubMed ID: 3209894
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction in venous thromboembolism by agents affecting platelet function.
    Salzman EW; Harris WH; DeSanctis RW
    N Engl J Med; 1971 Jun; 284(23):1287-92. PubMed ID: 5576438
    [No Abstract]   [Full Text] [Related]  

  • 11. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thromboembolism prevention after heart valve prosthesis in an experimental model].
    Dragojevic D; Hetzer R; Corterier H
    Thoraxchir Vask Chir; 1972 Dec; 20(6):419-23. PubMed ID: 4539570
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis prevention and platelet functions following heart valve replacement].
    Aosaki M; Kitamura N
    Nihon Rinsho; 1978 Dec; 36(12):3874-83. PubMed ID: 372627
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves.
    Altman R; Boullon F; Rouvier J; Raca R; de la Fuente L; Favaloro R
    J Thorac Cardiovasc Surg; 1976 Jul; 72(1):127-9. PubMed ID: 1084448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
    Dale J; Myhre E; Rootwelt K
    Am Heart J; 1975 May; 89(5):613-8. PubMed ID: 1119369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.